We value your privacy

This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.

Powered by

Vagifem

ACNU Feasibility

View full report
OKVagifem, a vaginal estradiol tablet, has notable safety risks including boxed warnings for serious conditions and requires careful monitoring and adherence to a complex dosing schedule, with low misuse potential but significant special population considerations.

ACNU Feasibility Scorecard

Chart with 11 data points.
Vagifem
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 2 to 8.
End of interactive chart.